Cumulative Subject Index Volumes 25 - 47 by Karl Maramorosch, Frederick A. Murphy, Aaron J. Shatkin

By Karl Maramorosch, Frederick A. Murphy, Aaron J. Shatkin

This quantity offers the index of Volumes 25-47 as a convenient connection with the contents. The sequence is geared toward virologists, microbiologists, immunologists, molecular biologists, pathologists, and plant researchers.

Show description

Read or Download Cumulative Subject Index Volumes 25 - 47 PDF

Similar science (general) books

Tourism in China: Destination, Cultures and Communities (Routledge Advances in Tourism, Volume 14)

China is forecast to be the first vacationer vacation spot and tourist-generating state by means of 2020. despite the fact that, a lot of the writing on tourism in China has come from humans in the English educational international who're now not keen on the problems on the topic of chinese language tourism improvement. This book offers a voice to chinese language mainland educational researchers and examines the character of tourism examine and tourism improvement in China.

Advances in International Accounting, Volume 17 (Advances in International Accounting)

Advances in foreign Accounting is a refereed, educational examine annual, that's dedicated to publishing articles approximately developments within the improvement of accounting and its similar disciplines from a world viewpoint. This serial examines how those advancements impact the monetary reporting and disclosure practices, taxation, administration accounting practices, and auditing of firm companies, in addition to their impression at the schooling accountants world wide.

Recent Advances in Spectroscopy: Theoretical, Astrophysical and Experimental Perspectives

In recent times there were nice advances within the fields of laboratory and astronomical spectroscopy. those were both matched through large-scale computations utilizing cutting-edge theoretical equipment. The exact atomic opacities which are to be had at the present time play a superb position within the box of biomedical study utilizing nanotechnology.

Extra info for Cumulative Subject Index Volumes 25 - 47

Example text

INDEX Antibody-dependent enhancement antibody specificity FcR for IgG subclasses, 31:344-345 IgG for viral determinants, 31:345347 species specificity of FcR, 31:344 in dengue viruses, 31:337-339 early studies on, 31:336-337 effects of macrophage activation, 31~349-351 flavivirus epitopes involved in, 31:151-159 in macrophage-like cell lines, 31:339 mechanisms, 31:341-347 complement receptors, 31:342-343 Fc receptors, 31:341-342 viral specificity, 31:343-344 viral replicationhestriction, 31:347349 and viral vaccines, 31:352 in viuo, 31:351-352 yellow fever virus type-specific and, cross-reactive MAbs, 31:155 Anticomplement immunofluorescence, human herpesvirus 6 and, 41:25 Antigenic drift, influenza virus type A, 31:62 Antigenic epitopes, synthetic peptides, 42:152-153 Antigenicity, of parvovirus nonstructural polypeptides, 33:128-132 Antigenic relationships ADRV, 35:202-205 asinine herpesvirus 3 with other viruses, 4 5 169- 173 coronaviruses, 2894-95 flaviviruses MAbs, 31:109-117 dengue virus, 31:113-117 yellow fever virus, 31:109-113 polyclonal sera, 31:107-108 serological subgroups, 31:107108 parvoviruses, 38418-423 toroviruses, 43:252-253 Antigenic structure, parvoviruses, 33:104-106 Antigenic variation flaviviruses epitopes involved in, 31:118-121 11 St.

OMP decarboxylase/CTP synthetase inhibitors, 42:lO-13 sulfated polysaccharides, 42:2-6 thymidine analogs, 4220-23 Antiviral antibody affinity, 34:283-285, 307-308 measurement direct definitions, 34:285-286 equations, 34:286-288 liquid-phase, 34288-295, 297 solid-phase, 34:295-297 valency, 34297-302 relative, 34302, 305 antibody binding, 34303-306 antibody competition, 34304-305 dissociative methods, 34:302-303 virus competition, 34306-307 Antiviral compound inhibitors attachment, 3084-85 macromolecular synthesis purine nucleosides, 3092-100 pyrimidine nucleosides, 30100-105 ribovarin, 30 105- 107 various compounds, 30107-112 maturation and assembly, 30112-115 penetration, 3085-88 replication early stages, 3090-91 uncoating, 3088-89 Antiviral compounds 2'-5'A analogs, 30:120-123 assay for activity, 2649 characteristics, 2648-49 effects infected cell cultures, 26:49-56 virus persistence, 2649-56 formulae, 2651 interferon type I inducers, 30116120 high-molecular weight, 30:117 low molecular weight, 30117-120 interferon type I1 inducers, 30120 for plant viruses, 26213-217 activity measurement, 26213-214 resistance and, 26214-217 resistance to, 2655-56 targeting with liposomes, 30124-125 MAbs, 30125 protein carriers, 30123-124 retrograde axonal transport, 30125126 with unknown mechanism of action, 30115-116 Antiviral drugs human herpesvirus 6 and, 41:24-25 translational suppression by retroviruses and, 41:233 Antiviral factor chemical nature, 26221-222 discovery and general activity, 26217219 interferon, 26226-229 localization and resistance, 26229-230 mode of action, 26225-226 purification, 26219-220 stimulation, 26:222-225 from TMV-infected plants, 26217-230 Ape CreutzfeldtJakob disease in, 297-8, 10-11 kuru in, 297-8, 10 Aphidicolin archaebacterial viruses and, 34:144 DNA replication and, 34:7 parvovirus gene expression and, 33: 140- 142 Aphididae as plant-virus vectors, 28114133 circulative viruses, 2 8 120- 121 feeding behavior, 28: 131-132 helpers for, 28118-120 plant effects, 28122 transmission participants, 28:116-123 transmission types, 28114-116 vector-plant interactions, 28127-131 vector-virus interaction, 28123-127 Aphids alarm pheromones, application of, 31:419 cell culture, 25262-264 cucumber mosaic virus and, 41:331, 333-337 numbers, and models for describing nonpersistent virus spread, 31:415-416 plant viruses in developing countries and crop improvement, 41:361, 372, 374375,377 remedial action, 41:383, 389-391 INDEX spread of banana bunchy top virus and, 33:317 transmission of closteroviruses, 25:118-120 as vectors for nonpersistent virus transmission, 31:394-395 Aphid-transmissible monopartite closteroviruses, genome organization and functions of gene products, 47:129- 135 Aphis, cucumber mosaic virus and, 41:333-335 Aphthouirus, picornaviral genomes and, 40104-105 Aphthoviruses, 39294-295 picornaviral genomes and cis-acting elements, 40126 phenotype, 40:157 RNA replication, 40154 structure, 4 0 105- 106, 108- 109 trans-acting factors, 40132 Apolipoprotein-B synthesis, 35120-122 Apoptosis, 451-50 altered surface properties, 45:6, 8 analysis, 453, 5-8 Bcl-2, protective effect, 4549 cell cycle role, 459-10, 48-49 cell shrinkage, 455-6 cellular genes and proteins in, 45:lO15 bcl-2, 45:13-15 C-fos, 4 5 1 1 C - ~ Y 4510 C, ~ 5 3 , 4 5 1 1 - 1 2 ,49 pRb, 4513 definition, 45:2 detection in situ, 455, 7 Fas/Apo-1 system, 4534-35 Fas/TNF receptor, functions, 4549 immunological memory impairment, 4547 interrelationship between cell proliferation and cell death, 45:48 killing mechanism by cytotoxic lymphocytes, 4523-26 in LCMV model, 4538-44 lymphocytes, 4532-34 nuclear changes during, 45:3-4 nuclear DNA fragmentation during, 453,5 protease role, 4549-50 15 subdiploid DNA content, 45:5-6 target susceptibility to CTL-mediated DNA fragmentation, 45:26-28 T lymphocyte activation-induced, 45:35-36 EBV-induced infectious mononucleosis, 4544-45 HIV infection, 4545-47 virus-induced, 4515-23 adenoviruses, 4515-16 baculoviruses, 4516-17 chicken anemia virus, 45:17-18 Epstein-Barr virus, 4518-19 HIV, 4519-21 influenza virus, 4521 papovaviruses, 45:21 parvoviruses, 45:22 Sindbis virus, 4522 spongiform encephalopathies, 452223 viral integration into apoptosis gene, 45:23 virus-infected cell lysis by TNF-a, 45:28-30 virus-infected targets mediated by B cells, 4530-32 Apple mosaic virus diagnosis, with MAb, 29:161 immunization of mice, 29:136 MAb-determined antigenic properties, 29150-151 Apple stem grooving virus, 25113-114 A protein, tobacco mosaic virus, 26148150 Aprotinin, influenza attachment inhibition, 3085 Ara-A, see Vidarabine Arabidopsis thaliana defective interfering viruses and, 40204 protoplast isolation, 29224 9P-D-Arabinofuranosyladenine, and derivatives, HSV inhibition, 3092-94 Arabis mosaic virus, 33:216 immunization of mice, 29136 MAb-determined antigenic properties, 29:152-153 MAbs, 29134 Plantago hosts and occurrence, 27:114, 126-127 positive hybridomas, 29140-142, 144 16 INDEX Arachidonic acid derivatives, respiratory defense mechanisms and, 35:236237 Arachis, plant viruses in developing countries and, 41:367, 369 Arboviruses Bunyaviridae and, 40235, 262 definition, 33328 mosquito transmission, 32277-279 Archaebacterial viruses, 34:143-147, 184-185 Halobacterium halobium bacteriophage @H genetic variability, 34:150-153 lysogens, 34153-157 Halobacterium halobium bacteriophage @N, 34:162-163 Halobacterium phages Hhl, 34:165-166 Hh3,34:166-167 Jal, 34:164-165 S45,34:167-168 Methanobrexibacter smithii, 34168 properties, 34147-149 transcription, 34157-162 Sulfolobus virus-like particle SSVl components, 34:179-181 DNA, 34177-179 features, 34174-177 transcription, 34181-184 Thermoproteus tenax properties, 34168-171 virus TTV1,34171-173 virus TTV2,34173-174 virus TTV3,34173-174 virus TTV4, 34174 Arenaviridae distribution, 31:3 isolation from rodents, 31:3-4 members, 31:2-5 vertebrate hosts, 31:3 Arenaviruses, 42:234 Bunyaviridae and, 40244,264 genetic attributes, 31:lO glycoproteins, surface projections, 31:5 infection cycle, 31:9-10 large protein L, 31:7 nucleocapsid protein N, 31:7 particle, schematic representation, 31:6 ribosomes, 31:8-9 RNA L and S species, 31:8 S species, ambisense coding arrangement, 31:lO-18 implications, 31:14-16 origin, 31:16-18 RNA polymerase activities, 31:7-8 shape, 31:5 size, 31:5 structural components, 31:5-9 structural proteins of, 31:5 viral envelope, 31:5-6 Arginine HEF glycoprotein of influenza C virus and, 40222 influenza virus and components, 34:252 pathogenicity, 34265-266, 268-270 Arildone HIV structure and, 3921 uncoating inhibition, 27165-166 HSV, 3089 poliovirus, 3088-89 Arima clones, hepatitis C virus and, 4075-76 Arthritis following rubella virus infection, 44:73 lentiviruses and, 34:189-190 virus-host cell interaction in uiuo, 34201,203-204 rheumatoid, 2947 Sindbis virus encephalitis and, 36255 Arthropathy, chronic, following rubella virus vaccination, 44:73-74 Arthropod-borne viruses, see also Bunyaviruses; Togaviruses animals, vectors, 31:305-306 Bunyaviridae and, 40235, 246, 262 plants, vectors, 31:306-307 Arthropods, viral transmission, 4 3 13 Arthropod vectors, transmission by, 42216-217 ASF, see African swine fever Asialofetuin, as antiviral drug carrier, 3 0 124 Asinine herpesvirus 3, antigenic relationships with other viruses, 45169173 L-Asparaginase, effect on persistent viral infections, 2657-58 INDEX Aspartyl protease PR, HIV structure and, 39:2, 5 pol gene products, 3924-29,39 Aspergillus japonicus, macerating enzyme, 29219 Aster ringspot virus, Plantago host and occurrence, 27114 Aster yellows, Plantago hosts and occurence of, 27116 Astrocytes, 42253-254, 258-259 Astrocytic foot processes, 42:258 Astrocytosis, prion diseases and, 35:89, 91-92 Astroviruses, 29188, 193, 43:25 ASV, see Avian sarcoma virus Ataxia feline panleukopenia virus and, 38412, 414 lentiviruses and, 34:201 ATF factor, in trans-activation of transcription, 37:61-63, 67-68 ATP (adenosine 5’-triphosphate) archaebacterial viruses and, 34178 cap binding proteins and, 33:178, 180184 DNA replication and, 3418-19 Epstein-Barr virus and, 4039 neurodegenerative diseases caused by prions and, 41:270 picornaviral genomes and, 40130-132, 140 ATPase, DNA replication and, 3418-19 Attachment, rubella virus, 44:105-106 Attachment proteins, 27:148-150, 167168, 175-176, 178-181, 185, 187, 189-192, 196 Attenuation, transcription by parvovirus and, 33:145 AUG Bunyaviridae and, 40:250, 252-253 picornaviral genomes and, 40:107-108 cis-acting elements, 40:114-117, 124, 126, 128 evolution, 40:158 mRNAs, 40143,145, 147, 149-151 trans-acting factors, 40131-133, 137 translation initiation, 40140-142 Australia, banana bunchy top virus infection control, 33:314-318 New South Wales, 33:319-322 17 Queensland, 33:321-322 Australia antigen, 47253 Autoantibodies, Theiler’s murine encephalomyelitis virus and, 39:308 Autocatalytic processing, hepatitis delta virus, 43:203-204 Autographa californica nucleopolyhedrosis virus, 35178-179 recombinant, foreign DNA sequences, 35189 Autoimmunity induction by paramyxoviridae, 37:234235 virus-related, 47365-367 lymphocytic choriomeningitis virustype species infection-induced, 31:9 modification of cellular antigens, 31:366-368 molecular mimicry, 31:368-369 polyclonal lymphocyte activation, 31:365-366 Autonomization, gene activation by, 2512 Autoradiography, vaccinia and, 345758 Auxins, viral infections and, 33:239-240 Auxotrophs, oral vaccination and, 41:432-435 Auena satiua, leaf protoplasts, virus infection, 29227 Avian erythroblastosis virus mutants td-130, transforming only fibroblasts, 32107 kinase domain deleted, 32:107-108 transforming erythroblasts and fibroblasts in uitro, 32:104 v-erbB gene identification as oncogene, 32:104106 nucleotide sequence, 32107 Avian influenza viruses, 42221-222 Avian leukemia virus, HIV-1 and, 40:l2 Avian leukosis virus delayed B-cell lymphoma induction, 30205-206 c - m y expression, 30207-209 enhancer insertion, 30207 LTR role, 30206-209 18 INDEX Avian leukosis virus (cont.

OMP decarboxylase/CTP synthetase inhibitors, 42:lO-13 sulfated polysaccharides, 42:2-6 thymidine analogs, 4220-23 Antiviral antibody affinity, 34:283-285, 307-308 measurement direct definitions, 34:285-286 equations, 34:286-288 liquid-phase, 34288-295, 297 solid-phase, 34:295-297 valency, 34297-302 relative, 34302, 305 antibody binding, 34303-306 antibody competition, 34304-305 dissociative methods, 34:302-303 virus competition, 34306-307 Antiviral compound inhibitors attachment, 3084-85 macromolecular synthesis purine nucleosides, 3092-100 pyrimidine nucleosides, 30100-105 ribovarin, 30 105- 107 various compounds, 30107-112 maturation and assembly, 30112-115 penetration, 3085-88 replication early stages, 3090-91 uncoating, 3088-89 Antiviral compounds 2'-5'A analogs, 30:120-123 assay for activity, 2649 characteristics, 2648-49 effects infected cell cultures, 26:49-56 virus persistence, 2649-56 formulae, 2651 interferon type I inducers, 30116120 high-molecular weight, 30:117 low molecular weight, 30117-120 interferon type I1 inducers, 30120 for plant viruses, 26213-217 activity measurement, 26213-214 resistance and, 26214-217 resistance to, 2655-56 targeting with liposomes, 30124-125 MAbs, 30125 protein carriers, 30123-124 retrograde axonal transport, 30125126 with unknown mechanism of action, 30115-116 Antiviral drugs human herpesvirus 6 and, 41:24-25 translational suppression by retroviruses and, 41:233 Antiviral factor chemical nature, 26221-222 discovery and general activity, 26217219 interferon, 26226-229 localization and resistance, 26229-230 mode of action, 26225-226 purification, 26219-220 stimulation, 26:222-225 from TMV-infected plants, 26217-230 Ape CreutzfeldtJakob disease in, 297-8, 10-11 kuru in, 297-8, 10 Aphidicolin archaebacterial viruses and, 34:144 DNA replication and, 34:7 parvovirus gene expression and, 33: 140- 142 Aphididae as plant-virus vectors, 28114133 circulative viruses, 2 8 120- 121 feeding behavior, 28: 131-132 helpers for, 28118-120 plant effects, 28122 transmission participants, 28:116-123 transmission types, 28114-116 vector-plant interactions, 28127-131 vector-virus interaction, 28123-127 Aphids alarm pheromones, application of, 31:419 cell culture, 25262-264 cucumber mosaic virus and, 41:331, 333-337 numbers, and models for describing nonpersistent virus spread, 31:415-416 plant viruses in developing countries and crop improvement, 41:361, 372, 374375,377 remedial action, 41:383, 389-391 INDEX spread of banana bunchy top virus and, 33:317 transmission of closteroviruses, 25:118-120 as vectors for nonpersistent virus transmission, 31:394-395 Aphid-transmissible monopartite closteroviruses, genome organization and functions of gene products, 47:129- 135 Aphis, cucumber mosaic virus and, 41:333-335 Aphthouirus, picornaviral genomes and, 40104-105 Aphthoviruses, 39294-295 picornaviral genomes and cis-acting elements, 40126 phenotype, 40:157 RNA replication, 40154 structure, 4 0 105- 106, 108- 109 trans-acting factors, 40132 Apolipoprotein-B synthesis, 35120-122 Apoptosis, 451-50 altered surface properties, 45:6, 8 analysis, 453, 5-8 Bcl-2, protective effect, 4549 cell cycle role, 459-10, 48-49 cell shrinkage, 455-6 cellular genes and proteins in, 45:lO15 bcl-2, 45:13-15 C-fos, 4 5 1 1 C - ~ Y 4510 C, ~ 5 3 , 4 5 1 1 - 1 2 ,49 pRb, 4513 definition, 45:2 detection in situ, 455, 7 Fas/Apo-1 system, 4534-35 Fas/TNF receptor, functions, 4549 immunological memory impairment, 4547 interrelationship between cell proliferation and cell death, 45:48 killing mechanism by cytotoxic lymphocytes, 4523-26 in LCMV model, 4538-44 lymphocytes, 4532-34 nuclear changes during, 45:3-4 nuclear DNA fragmentation during, 453,5 protease role, 4549-50 15 subdiploid DNA content, 45:5-6 target susceptibility to CTL-mediated DNA fragmentation, 45:26-28 T lymphocyte activation-induced, 45:35-36 EBV-induced infectious mononucleosis, 4544-45 HIV infection, 4545-47 virus-induced, 4515-23 adenoviruses, 4515-16 baculoviruses, 4516-17 chicken anemia virus, 45:17-18 Epstein-Barr virus, 4518-19 HIV, 4519-21 influenza virus, 4521 papovaviruses, 45:21 parvoviruses, 45:22 Sindbis virus, 4522 spongiform encephalopathies, 452223 viral integration into apoptosis gene, 45:23 virus-infected cell lysis by TNF-a, 45:28-30 virus-infected targets mediated by B cells, 4530-32 Apple mosaic virus diagnosis, with MAb, 29:161 immunization of mice, 29:136 MAb-determined antigenic properties, 29150-151 Apple stem grooving virus, 25113-114 A protein, tobacco mosaic virus, 26148150 Aprotinin, influenza attachment inhibition, 3085 Ara-A, see Vidarabine Arabidopsis thaliana defective interfering viruses and, 40204 protoplast isolation, 29224 9P-D-Arabinofuranosyladenine, and derivatives, HSV inhibition, 3092-94 Arabis mosaic virus, 33:216 immunization of mice, 29136 MAb-determined antigenic properties, 29:152-153 MAbs, 29134 Plantago hosts and occurrence, 27:114, 126-127 positive hybridomas, 29140-142, 144 16 INDEX Arachidonic acid derivatives, respiratory defense mechanisms and, 35:236237 Arachis, plant viruses in developing countries and, 41:367, 369 Arboviruses Bunyaviridae and, 40235, 262 definition, 33328 mosquito transmission, 32277-279 Archaebacterial viruses, 34:143-147, 184-185 Halobacterium halobium bacteriophage @H genetic variability, 34:150-153 lysogens, 34153-157 Halobacterium halobium bacteriophage @N, 34:162-163 Halobacterium phages Hhl, 34:165-166 Hh3,34:166-167 Jal, 34:164-165 S45,34:167-168 Methanobrexibacter smithii, 34168 properties, 34147-149 transcription, 34157-162 Sulfolobus virus-like particle SSVl components, 34:179-181 DNA, 34177-179 features, 34174-177 transcription, 34181-184 Thermoproteus tenax properties, 34168-171 virus TTV1,34171-173 virus TTV2,34173-174 virus TTV3,34173-174 virus TTV4, 34174 Arenaviridae distribution, 31:3 isolation from rodents, 31:3-4 members, 31:2-5 vertebrate hosts, 31:3 Arenaviruses, 42:234 Bunyaviridae and, 40244,264 genetic attributes, 31:lO glycoproteins, surface projections, 31:5 infection cycle, 31:9-10 large protein L, 31:7 nucleocapsid protein N, 31:7 particle, schematic representation, 31:6 ribosomes, 31:8-9 RNA L and S species, 31:8 S species, ambisense coding arrangement, 31:lO-18 implications, 31:14-16 origin, 31:16-18 RNA polymerase activities, 31:7-8 shape, 31:5 size, 31:5 structural components, 31:5-9 structural proteins of, 31:5 viral envelope, 31:5-6 Arginine HEF glycoprotein of influenza C virus and, 40222 influenza virus and components, 34:252 pathogenicity, 34265-266, 268-270 Arildone HIV structure and, 3921 uncoating inhibition, 27165-166 HSV, 3089 poliovirus, 3088-89 Arima clones, hepatitis C virus and, 4075-76 Arthritis following rubella virus infection, 44:73 lentiviruses and, 34:189-190 virus-host cell interaction in uiuo, 34201,203-204 rheumatoid, 2947 Sindbis virus encephalitis and, 36255 Arthropathy, chronic, following rubella virus vaccination, 44:73-74 Arthropod-borne viruses, see also Bunyaviruses; Togaviruses animals, vectors, 31:305-306 Bunyaviridae and, 40235, 246, 262 plants, vectors, 31:306-307 Arthropods, viral transmission, 4 3 13 Arthropod vectors, transmission by, 42216-217 ASF, see African swine fever Asialofetuin, as antiviral drug carrier, 3 0 124 Asinine herpesvirus 3, antigenic relationships with other viruses, 45169173 L-Asparaginase, effect on persistent viral infections, 2657-58 INDEX Aspartyl protease PR, HIV structure and, 39:2, 5 pol gene products, 3924-29,39 Aspergillus japonicus, macerating enzyme, 29219 Aster ringspot virus, Plantago host and occurrence, 27114 Aster yellows, Plantago hosts and occurence of, 27116 Astrocytes, 42253-254, 258-259 Astrocytic foot processes, 42:258 Astrocytosis, prion diseases and, 35:89, 91-92 Astroviruses, 29188, 193, 43:25 ASV, see Avian sarcoma virus Ataxia feline panleukopenia virus and, 38412, 414 lentiviruses and, 34:201 ATF factor, in trans-activation of transcription, 37:61-63, 67-68 ATP (adenosine 5’-triphosphate) archaebacterial viruses and, 34178 cap binding proteins and, 33:178, 180184 DNA replication and, 3418-19 Epstein-Barr virus and, 4039 neurodegenerative diseases caused by prions and, 41:270 picornaviral genomes and, 40130-132, 140 ATPase, DNA replication and, 3418-19 Attachment, rubella virus, 44:105-106 Attachment proteins, 27:148-150, 167168, 175-176, 178-181, 185, 187, 189-192, 196 Attenuation, transcription by parvovirus and, 33:145 AUG Bunyaviridae and, 40:250, 252-253 picornaviral genomes and, 40:107-108 cis-acting elements, 40:114-117, 124, 126, 128 evolution, 40:158 mRNAs, 40143,145, 147, 149-151 trans-acting factors, 40131-133, 137 translation initiation, 40140-142 Australia, banana bunchy top virus infection control, 33:314-318 New South Wales, 33:319-322 17 Queensland, 33:321-322 Australia antigen, 47253 Autoantibodies, Theiler’s murine encephalomyelitis virus and, 39:308 Autocatalytic processing, hepatitis delta virus, 43:203-204 Autographa californica nucleopolyhedrosis virus, 35178-179 recombinant, foreign DNA sequences, 35189 Autoimmunity induction by paramyxoviridae, 37:234235 virus-related, 47365-367 lymphocytic choriomeningitis virustype species infection-induced, 31:9 modification of cellular antigens, 31:366-368 molecular mimicry, 31:368-369 polyclonal lymphocyte activation, 31:365-366 Autonomization, gene activation by, 2512 Autoradiography, vaccinia and, 345758 Auxins, viral infections and, 33:239-240 Auxotrophs, oral vaccination and, 41:432-435 Auena satiua, leaf protoplasts, virus infection, 29227 Avian erythroblastosis virus mutants td-130, transforming only fibroblasts, 32107 kinase domain deleted, 32:107-108 transforming erythroblasts and fibroblasts in uitro, 32:104 v-erbB gene identification as oncogene, 32:104106 nucleotide sequence, 32107 Avian influenza viruses, 42221-222 Avian leukemia virus, HIV-1 and, 40:l2 Avian leukosis virus delayed B-cell lymphoma induction, 30205-206 c - m y expression, 30207-209 enhancer insertion, 30207 LTR role, 30206-209 18 INDEX Avian leukosis virus (cont.

Download PDF sample

Rated 4.85 of 5 – based on 6 votes